David J. Clark, Chief Medical Officer at Aldeyra Therapeutics, Inc. (ALDX), bought 5,000 shares at $5.06 ($25K) on 2019-09-06, disclosed to the SEC on 2019-09-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.